Article

Cost-Effectiveness Analysis of Genomic Profiling in Early Breast Cancer in Colombia

2021-08-24

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> In Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study aimed to identify the cost-effectiveness of various strategies to establish the necessity of adjuvant chemotherapy.<bold>Methods: </bold>This study used an adapted decision-analytic model to compare cost and outcomes of care t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9613ed39-80b9-59f9-a3f9-7998d224b7fb
DOI: 10.21203/rs.3.rs-264520/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost-Effectiveness Analysis of Genomic Profiling in Early Breast Cancer in ColombiaDOI 10.21203/rs.3.rs-264520/v2Read

Cost-utility analysis of genomic profiling in early breast cancer in ColombiaSemantic proximity Read

Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.Semantic proximity Read

Estimated survival outcomes and absolute chemotherapy treatment benefit using PREDICT Tool® and EndoPredict®, in hormone-positive early-stage breast cancer.Semantic proximity Read

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.Semantic proximity Read

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trialSemantic proximity Read

Neoadjuvant Chemotherapy in early-stage breast cancer: the trend over time and the impact on axillary management, A National Cancer Database AnalysisSemantic proximity Read

Omission of Chemotherapy in HR+/HER2- Early Invasive Breast Cancer Based on Combined 6-IHC Score?Semantic proximity Read

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china.Semantic proximity Read

[Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience].Semantic proximity Read

Personalized recurrence risk prediction in early-stage breast cancer through an integrative mathematical model based on MammaPrint®, radiotherapy, phenotype, and clinicopathological factors.Semantic proximity Read

Estimation of Healthcare-related Charges in Women with BRCA Mutations and Breast Cancer Semantic proximity Read

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income CountrySemantic proximity Read